Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biofrontera (BFRI)
NASDAQ:BFRI
Holding BFRI?
Track your performance easily
Earnings Data
Report Date
Apr 04, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
-$0.03Last Year’s EPS
-$2.88Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 13, 2024
|% Change Since: 17.41%
|Next Earnings Date:Apr 04, 2025
Earnings Call Sentiment|Positive
The earnings call highlighted Biofrontera's strong revenue growth and effective cost management, alongside strategic initiatives such as the introduction of new products and improved formulations. However, challenges remain with increased costs of revenues and ongoing trial expenses impacting financials. Despite these challenges, the overall sentiment is positive due to significant achievements and strategic positioning for future growth.Company Guidance
During the Biofrontera Inc. Q2 2024 earnings call, the company reported a 34% increase in sales for the quarter, reaching $7.8 million compared to $5.8 million in Q2 2023. This growth was attributed to recovering from Q1's sales decline due to reimbursement challenges and increasing productivity. Operating expenses decreased to $12.9 million from $14.5 million in the previous year, with SG&A expenses significantly reduced to $7.9 million from $11.6 million. The net loss was reduced to $257,000 from $9.8 million, and adjusted EBITDA improved to negative $4.7 million from negative $7.9 million. The balance sheet was strengthened by raising $8 million from exercised warrants and extinguishing short-term debt, with cash and cash equivalents increasing to $4.4 million. Biofrontera also emphasized progress in R&D with ongoing trials and anticipated FDA updates for Ameluz, reflecting a stable financial outlook and strategic growth plans.Significant Revenue Growth
Biofrontera reported a 34% increase in total revenues for the second quarter of 2024 compared to the second quarter of 2023, with revenues reaching $7.8 million.
Successful Cost Management
Total operating expenses decreased to $12.9 million in Q2 2024 from $14.5 million in Q2 2023. SG&A expenses also decreased to $7.9 million from $11.5 million in the same period.
Debt Reduction and Financial Stability
Biofrontera paid down all outstanding debt in the second quarter and increased cash and cash equivalents to $4.4 million as of June 30, 2024, compared to $1.3 million at the end of 2023.
Introduction of RhodoLED XL Lamp
The company began sales of the FDA-approved RhodoLED XL lamp on June 10, 2024, which is expected to enhance treatment options for actinic keratosis.
Improved Product Offering
The FDA approved a new formulation of Ameluz lacking propylene glycol, improving tolerability and potentially extending shelf life.
---
BFRI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
BFRI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 13, 2024 | $0.83 | $0.70 | -15.66% |
| Aug 14, 2024 | $1.14 | $1.16 | +1.75% |
| May 15, 2024 | $1.21 | $1.09 | -9.92% |
| Mar 15, 2024 | $1.55 | $1.26 | -18.71% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Biofrontera (BFRI) report earnings?
Biofrontera (BFRI) is schdueled to report earning on Apr 04, 2025, TBA Not Confirmed.
What is Biofrontera (BFRI) earnings time?
Biofrontera (BFRI) earnings time is at Apr 04, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is BFRI EPS forecast?
BFRI EPS forecast for the fiscal quarter 2024 (Q4) is -$0.03.
---